title: Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent.
abstract: Recent advances demonstrate a relationship between chronic/recurrent inflammation and prostate cancer (PCA). Among inflammatory regulators, toll-like receptors (TLRs) have a critical role in innate immune responses. However, it remains unclear whether variant TLR genes influence PCA risk among men of African descent. Therefore, we evaluated the impact of 32 TLR-associated single-nucleotide polymorphisms (SNPs) on PCA risk among African Americans and Jamaicans. SNP profiles of 814 subjects were evaluated using Illumina's Veracode genotyping platform. Single and combined effects of SNPs in relation to PCA risk were assessed using age-adjusted logistic regression and entropy-based multifactor dimensionality reduction (MDR) models. Seven sequence variants detected in TLR6, TOLLIP (Toll-interacting protein), IRAK4 (interleukin-1 receptor-associated kinase 4) and IRF3 (interferon regulatory factor 3) were marginally related to PCA. However, none of these effects remained significant after adjusting for multiple hypothesis testing. Nevertheless, MDR modeling revealed a complex interaction between IRAK4 rs4251545 and TLR2 rs1898830 as a significant predictor of PCA risk among US men (permutation testing P-value=0.001). However, these findings require further assessment and validation.
authors: Department of Pharmacology and Toxicology, University of Louisville, Clinical and Translational Research Building, 505 South Hancock Street, Room 306, Louisville, KY 40202, USA.
authors: E N
authors: EN
authors: Rogers
authors: D Z
authors: DZ
authors: Jones
authors: N C
authors: NC
authors: Kidd
authors: S
authors: S
authors: Yeyeodu
authors: G
authors: G
authors: Brock
authors: C
authors: C
authors: Ragin
authors: M
authors: M
authors: Jackson
authors: N
authors: N
authors: McFarlane-Anderson
authors: M
authors: M
authors: Tulloch-Reid
authors: K
authors: K
authors: Sean Kimbro
authors: L R
authors: LR
authors: Kidd
mesh_terms: D001741:Black or African American / Q000235:genetics*; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D050838:Interferon Regulatory Factor-3 / Q000235:genetics; D053592:Interleukin-1 Receptor-Associated Kinases / Q000235:genetics; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000208:ethnology / Q000235:genetics*; D051195:Toll-Like Receptor 2 / Q000235:genetics*; D051216:Toll-Like Receptor 6 / Q000235:genetics*
chemical_list: C494232:IRF3 protein, human; D050838:Interferon Regulatory Factor-3; D047908:Intracellular Signaling Peptides and Proteins; C495342:TLR2 protein, human; C495368:TLR6 protein, human; C410602:TOLLIP protein, human; D051195:Toll-Like Receptor 2; D051216:Toll-Like Receptor 6; C507773:IRAK4 protein, human; D053592:Interleukin-1 Receptor-Associated Kinases
references: Cell. 2007 Sep 21;130(6):1071-82
references: 17889651
references: Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1004-12
references: 17855767
references: BMC Genet. 2008 May 13;9:36
references: 18477402
references: Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):444-54
references: 17653117
references: Cancer Prev Res (Phila). 2009 Mar;2(3):244-50
references: 19240249
references: Immunogenetics. 2005 Jul;57(6):385-92
references: 16001129
references: Shock. 2008 Mar;29(3):315-21
references: 18277854
references: Cancer Causes Control. 2012 Jan;23(1):23-33
references: 21984307
references: Cell Microbiol. 2006 Dec;8(12):1899-909
references: 16848791
references: PLoS One. 2010 Mar 10;5(3):e9637
references: 20224791
references: Nat Rev Cancer. 2007 Apr;7(4):256-69
references: 17384581
references: Bioinformatics. 2010 Feb 15;26(4):445-55
references: 20053841
references: J Leukoc Biol. 2008 Mar;83(3):692-701
references: 18056480
references: Cancer Epidemiol Biomarkers Prev. 2010 Mar;19(3):873-6
references: 20200442
references: World J Urol. 2012 Apr;30(2):225-32
references: 21553150
references: Cancer Genet Cytogenet. 2009 Apr 15;190(2):88-92
references: 19380025
references: J Investig Allergol Clin Immunol. 2010;20(4):340-6
references: 20815312
references: Nature. 1991 May 30;351(6325):355-6
references: 1851964
references: Biomark Cancer. 2011 Feb 3;2011(3):1-13
references: 21709725
references: Int J Cancer. 2012 Jun 15;130(12):2974-80
references: 21792899
references: Int J Cancer. 2008 Dec 1;123(11):2644-50
references: 18752252
references: FEBS Lett. 1991 Oct 7;291(1):87-91
references: 1657640
references: PLoS One. 2009 Jun 02;4(6):e5639
references: 19503614
references: Gastroenterology. 2007 Mar;132(3):905-12
references: 17324405
references: J Biol Chem. 2002 Dec 6;277(49):47834-43
references: 12324469
references: Carcinogenesis. 2005 Jul;26(7):1170-81
references: 15498784
references: Am J Hum Genet. 2006 Oct;79(4):640-9
references: 16960800
references: Nat Rev Cancer. 2009 Jan;9(1):57-63
references: 19052556
references: Cell Death Differ. 2012 Apr;19(4):722-31
references: 22158417
references: PLoS One. 2010 Oct 12;5(10):e13271
references: 20967259
references: Histopathology. 2012 Jan;60(1):199-215
references: 22212087
references: J Leukoc Biol. 2000 Apr;67(4):450-6
references: 10770275
references: Immunity. 2010 Mar 26;32(3):305-15
references: 20346772
references: Adv Exp Med Biol. 2005;560:29-39
references: 15934170
references: Annu Rev Pharmacol Toxicol. 2003;43:609-28
references: 12540749
references: Cancer Res. 2004 Apr 15;64(8):2918-22
references: 15087412
references: Eur J Immunol. 2007 Dec;37(12):3311-8
references: 18034428
references: Int J Cancer. 2010 Dec 15;127(12):2893-917
references: 21351269
references: PLoS One. 2011 Jan 21;6(1):e16449
references: 21283657
references: Can J Urol. 2000 Oct;7(5):1091-8
references: 11114871
references: Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1356-61
references: 20406964
references: J Natl Cancer Inst. 2005 Apr 6;97(7):525-32
references: 15812078
references: Cancer Res. 2005 Dec 15;65(24):11771-8
references: 16357190
references: Mol Immunol. 2011 Jul;48(12-13):1349-59
references: 21481475
references: J Theor Biol. 2006 Jul 21;241(2):252-61
references: 16457852
references: Mol Vis. 2007 Oct 17;13:1953-61
references: 17982419
references: Gynecol Oncol. 2009 Sep;114(3):501-5
references: 19541348
references: Crit Care. 2011;15(1):R12
references: 21219635
references: Bioinformatics. 2007 Aug 15;23(16):2147-54
references: 17586552
references: Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-5
references: 17301271
references: Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):480-5
references: 16537705
references: Biochem Soc Trans. 2003 Jun;31(Pt 3):637-42
references: 12773172
references: Hum Hered. 2010;70(3):219-25
references: 20924193
references: Int J Cancer. 2000 Jan 1;85(1):60-7
references: 10585584
references: BioData Min. 2009 Sep 22;2(1):5
references: 19772641
references: Oncogene. 2008 Jan 7;27(2):218-24
references: 18176603
references: Genetics. 2003 Aug;164(4):1567-87
references: 12930761
references: Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1982-9
references: 17932345